These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 22738256)
21. The uremic dyslipidemia: a cross-sectional and longitudinal study. Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199 [TBL] [Abstract][Full Text] [Related]
22. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Borazan A; Aydemir S; Sert M; Yilmaz A Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053 [TBL] [Abstract][Full Text] [Related]
23. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients. Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770 [TBL] [Abstract][Full Text] [Related]
24. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928 [TBL] [Abstract][Full Text] [Related]
25. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
26. Levels of renalase and advanced oxidation protein products with regard to catecholamines in haemodialysed patients. Dziedzic M; Orłowska E; Petkowicz B; Bednarek-Skublewska A; Solski J; Goździewska M Ann Agric Environ Med; 2017 Sep; 24(3):453-458. PubMed ID: 28954489 [TBL] [Abstract][Full Text] [Related]
27. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein. Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580 [TBL] [Abstract][Full Text] [Related]
32. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis. Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216 [TBL] [Abstract][Full Text] [Related]
33. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Alagozlu H; Gorgul A; Bilgihan A; Tuncer C; Unal S Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):80-5. PubMed ID: 22572519 [TBL] [Abstract][Full Text] [Related]
34. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068 [TBL] [Abstract][Full Text] [Related]
35. Comparison of long-term survival between hemodialysis and peritoneal dialysis. Maiorca R; Cancarini GC; Brunori G; Zubani R; Camerini C; Manili L; Movilli E Adv Perit Dial; 1996; 12():79-88. PubMed ID: 8865878 [TBL] [Abstract][Full Text] [Related]
36. Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients. Muñoz-Cortés M; Cabré C; Villa D; Vives JP; Arruche M; Soler J; Compte MT; Aguilera J; Jariod M; Romeu M; Giralt M; Martinez-Vea A Clin Nephrol; 2013 Sep; 80(3):187-97. PubMed ID: 23743154 [TBL] [Abstract][Full Text] [Related]
37. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719 [TBL] [Abstract][Full Text] [Related]
38. Dementia and depression in end stage renal disease: comparison between hemodialysis and continuous ambulatory peritoneal dialysis. Sithinamsuwan P; Niyasom S; Nidhinandana S; Supasyndh O J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S141-7. PubMed ID: 16858952 [TBL] [Abstract][Full Text] [Related]
39. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Kim SB; Min WK; Lee SK; Park JS; Hong CD; Yang WS Am J Kidney Dis; 2002 Feb; 39(2):342-6. PubMed ID: 11840375 [TBL] [Abstract][Full Text] [Related]